최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Cell communication and signaling : CCS, v.15 no.1, 2017년, pp.9 -
Bommer, Ulrich-Axel (Illawarra Health and Medical Research Institute (IHMRI), University of Wollongong, Northfields Avenue, Wollongong, NSW 2522 Australia) , Vine, Kara L. (Illawarra Health and Medical Research Institute (IHMRI), University of Wollongong, Northfields Avenue, Wollongong, NSW 2522 Australia) , Puri, Prianka (Graduate School of Medicine, University of Wollongong, Northfields Avenue, Wollongong, NSW 2522 Australia) , Engel, Martin (Illawarra Health and Medical Research Institute (IHMRI), University of Wollongong, Northfields Avenue, Wollongong, NSW 2522 Australia) , Belfiore, Lisa (Illawarra Health and Medical Research Institute (IHMRI), University of Wollongong, Northfields Avenue, Wollongong, NSW 2522 Australia) , Fildes, Karen (Illawarra Health and Medical Research Institute (IHMRI), University of Wollongong, Northfields Avenue, Wollongong, NSW 2522 Australia) , Batterham, Marijka (School of Mathematics and Applied Statistics, Faculty of Engineering and Information Sciences University of Wollongong, Wollongong, 2522 NSW Australia) , Lochhead, Alistair (Illawarra Health and Medical Research Institute (IHMRI), Un) , Aghmesheh, Morteza
BackgroundTranslationally controlled tumour protein TCTP is an anti-apoptotic protein frequently overexpressed in cancers, where high levels are often associated with poor patient outcome. TCTP may be involved in protecting cancer cells against the cytotoxic action of anti-cancer drugs. Here we stud...
1. Lech G Slotwinski R Slodkowski M Krasnodebski IW Colorectal cancer tumour markers and biomarkers: Recent therapeutic advances World J Gastroenterol 2016 22 5 1745 1755 10.3748/wjg.v22.i5.1745 26855534
2. Arvelo F Sojo F Cotte C Biology of colorectal cancer Ecancermedical sci 2015 9 520
3. Siegel R Desantis C Jemal A Colorectal cancer statistics, 2014 CA Cancer J Clin 2014 64 2 104 117 10.3322/caac.21220 24639052
4. WHO Factsheet Cancer 2015 (Fact sheet N°297) 2015
5. De Divitiis C Nasti G Montano M Fisichella R Iaffaioli RV Berretta M Prognostic and predictive response factors in colorectal cancer patients: between hope and reality World J Gastroenterol 2014 20 41 15049 15059 10.3748/wjg.v20.i41.15049 25386053
6. Petrelli N Herrera L Rustum Y Burke P Creaven P Stulc J Emrich LJ Mittelman A A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma J Clin Oncol Off J Am Soc Clin Oncol 1987 5 10 1559 1565
7. Petrelli N Douglass HO Jr Herrera L Russell D Stablein DM Bruckner HW Mayer RJ Schinella R Green MD Muggia FM The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group J Clin Oncol Off J Am Soc Clin Oncol 1989 7 10 1419 1426
8. Grothey A Van Cutsem E Sobrero A Siena S Falcone A Ychou M Humblet Y Bouche O Mineur L Barone C Regorafenib monotherapy for previously treated metastatic colorectal cancer (CORRECT): an international, multicentre, randomised, placebo-controlled, phase 3 trial Lancet 2013 381 9863 303 312 10.1016/S0140-6736(12)61900-X 23177514
9. Nielsen DL Palshof JA Larsen FO Jensen BV Pfeiffer P A systematic review of salvage therapy to patients with metastatic colorectal cancer previously treated with fluorouracil, oxaliplatin and irinotecan +/− targeted therapy Cancer Treat Rev 2014 40 6 701 715 10.1016/j.ctrv.2014.02.006 24731471
10. Hammond WA Swaika A Mody K Pharmacologic resistance in colorectal cancer: a review Ther Adv Med Oncol 2016 8 1 57 84 26753006
11. Acunzo J Baylot V So A Rocchi P TCTP as therapeutic target in cancers Cancer Treat Rev 2014 40 6 760 769 10.1016/j.ctrv.2014.02.007 24650927
12. Bommer UA Cellular Function and Regulation of the Translationally Controlled Tumour Protein TCTP Open Allergy J 2012 5 19 32 10.2174/1874838401205010019
13. Jung J Kim HY Maeng J Kim M Shin DH Lee K Interaction of translationally controlled tumor protein with Apaf-1 is involved in the development of chemoresistance in HeLa cells BMC Cancer 2014 14 165 10.1186/1471-2407-14-165 24606760
14. Nagano-Ito M Ichikawa S Biological effects of Mammalian translationally controlled tumor protein (TCTP) on cell death, proliferation, and tumorigenesis Biochem Res Int 2012 2012 204960 10.1155/2012/204960 22675633
15. Thebault S Agez M Chi X Stojko J Cura V Telerman SB Maillet L Gautier F Billas-Massobrio I Birck C TCTP contains a BH3-like domain, which instead of inhibiting, activates Bcl-xL Sci Rep 2016 6 19725 10.1038/srep19725 26813996
16. Chen SH Wu P-S Chou C-H Yan Y-T Liu H Weng S-Y Yang-Yen H-F A knockout mouse approach reveals that TCTP functions as an essential factor for cell proliferation and survival in a tissue- or cell type-specific manner Mol Biol Cell 2007 18 7 2525 2532 10.1091/mbc.E07-02-0188 17475776
17. Susini L Besse S Duflaut D Lespagnol A Beekman C Fiucci G Atkinson AR Busso D Poussin P Marine JC TCTP protects from apoptotic cell death by antagonizing bax function Cell Death Differ 2008 15 8 1211 1220 10.1038/cdd.2008.18 18274553
18. Lucibello M Gambacurta A Zonfrillo M Pierimarchi P Serafino A Rasi G Rubartelli A Garaci E TCTP is a critical survival factor that protects cancer cells from oxidative stress-induced cell-death Exp Cell Res 2011 317 17 2479 2489 10.1016/j.yexcr.2011.07.012 21801721
19. Nagano-Ito M Banba A Ichikawa S Functional cloning of genes that suppress oxidative stress-induced cell death: TCTP prevents hydrogen peroxide-induced cell death FEBS Lett 2009 583 8 1363 1367 10.1016/j.febslet.2009.03.045 19328788
20. Gnanasekar M Dakshinamoorthy G Ramaswamy K Translationally controlled tumor protein is a novel heat shock protein with chaperone-like activity Biochem Biophys Res Commun 2009 386 2 333 337 10.1016/j.bbrc.2009.06.028 19523440
21. Bommer UA Heng C Perrin A Dash P Lobov S Elia A Clemens MJ Roles of the translationally controlled tumour protein (TCTP) and the double-stranded RNA-dependent protein kinase, PKR, in cellular stress responses Oncogene 2010 29 5 763 773 10.1038/onc.2009.380 19901967
22. Zhang J de Toledo SM Pandey BN Guo G Pain D Li H Azzam EI Role of the translationally controlled tumor protein in DNA damage sensing and repair Proc Natl Acad Sci U S A 2012 109 16 E926 933 10.1073/pnas.1106300109 22451927
23. Cans C Passer BJ Shalak V Nancy-Portebois V Crible V Amzallag N Allanic D Tufino R Argentini M Moras D Translationally controlled tumor protein acts as a guanine nucleotide dissociation inhibitor on the translation elongation factor eEF1A Proc Natl Acad Sci U S A 2003 100 24 13892 13897 10.1073/pnas.2335950100 14623968
24. Langdon JM Vonakis BM MacDonald SM Identification of the interaction between the human recombinant histamine releasing factor/translationally controlled tumor protein and elongation factor-1 delta (also known as eElongation factor-1B beta) Biochim Biophys Acta 2004 1688 3 232 236 10.1016/j.bbadis.2003.12.007 15062873
25. Wu H Gong W Yao X Wang J Perrett S Feng Y Evolutionarily conserved binding of translationally controlled tumor protein to eukaryotic elongation factor 1B J Biol Chem 2015 290 14 8694 8710 10.1074/jbc.M114.628594 25635048
26. Gachet Y Tournier S Lee M Lazaris-Karatzas A Poulton T Bommer UA The growth-related, translationally controlled protein P23 has properties of a tubulin binding protein and associates transiently with microtubules during the cell cycle J Cell Sci 1999 112 Pt 8 1257 1271 10085260
27. Yarm FR Plk phosphorylation regulates the microtubule-stabilizing protein TCTP Mol Cell Biol 2002 22 17 6209 6221 10.1128/MCB.22.17.6209-6221.2002 12167714
28. Jeon HJ You SY Park YS Chang JW Kim JS Oh JS TCTP regulates spindle microtubule dynamics by stabilizing polar microtubules during mouse oocyte meiosis Biochim Biophys Acta 2016 1863 4 630 637 10.1016/j.bbamcr.2016.01.012 26802898
29. Amson R Karp JE Telerman A Lessons from tumor reversion for cancer treatment Curr Opin Oncol 2013 25 1 59 65 10.1097/CCO.0b013e32835b7d21 23165143
30. Chan TH Chen L Guan XY Role of translationally controlled tumor protein in cancer progression Biochem Res Int 2012 2012 369384 10.1155/2012/369384 22570787
31. Amson R Pece S Lespagnol A Vyas R Mazzarol G Tosoni D Colaluca I Viale G Rodrigues-Ferreira S Wynendaele J Reciprocal repression between P53 and TCTP Nat Med 2012 18 1 91 99 10.1038/nm.2546
32. Chan TH Chen L Liu M Hu L Zheng BJ Poon VK Huang P Yuan YF Huang JD Yang J Translationally controlled tumor protein induces mitotic defects and chromosome missegregation in hepatocellular carcinoma development Hepatology 2012 55 2 491 505 10.1002/hep.24709 21953552
33. Chen C Deng Y Hua M Xi Q Liu R Yang S Liu J Zhong J Tang M Lu S Expression and clinical role of TCTP in epithelial ovarian cancer J Mol Histol 2015 46 2 145 156 10.1007/s10735-014-9607-y 25564355
34. Miao X Chen YB Xu SL Zhao T Liu JY Li YR Wang J Zhang J Guo GZ TCTP overexpression is associated with the development and progression of glioma Tumour Biol 2013 34 6 3357 3361 10.1007/s13277-013-0906-9 23749504
35. Telerman A Amson R The molecular programme of tumour reversion: the steps beyond malignant transformation Nat Rev Cancer 2009 9 3 206 216 10.1038/nrc2589 19180095
36. Tuynder M Fiucci G Prieur S Lespagnol A Geant A Beaucourt S Duflaut D Besse S Susini L Cavarelli J Translationally controlled tumor protein is a target of tumor reversion Proc Natl Acad Sci U S A 2004 101 43 15364 15369 10.1073/pnas.0406776101 15489264
37. Chen Y Fujita T Zhang D Doan H Pinkaew D Liu Z Wu J Koide Y Chiu A Lin CC Physical and functional antagonism between tumor suppressor protein p53 and fortilin, an anti-apoptotic protein J Biol Chem 2011 286 32575 32585 10.1074/jbc.M110.217836 21795694
38. Rho SB Lee JH Park MS Byun HJ Kang S Seo SS Kim JY Park SY Anti-apoptotic protein TCTP controls the stability of the tumor suppressor p53 FEBS Lett 2011 585 1 29 35 10.1016/j.febslet.2010.11.014 21081126
39. Bae SY Kim HJ Lee KJ Lee K Translationally controlled tumor protein induces epithelial to mesenchymal transition and promotes cell migration, invasion and metastasis Sci Rep 2015 5 8061 10.1038/srep08061 25622969
40. Lucibello M Adanti S Antelmi E Dezi D Ciafre S Carcangiu ML Zonfrillo M Nicotera G Sica L De Braud F Phospho-TCTP as a therapeutic target of Dihydroartemisinin for aggressive breast cancer cells Oncotarget 2015 6 7 5275 5291 10.18632/oncotarget.2971 25779659
41. Baylot V Katsogiannou M Andrieu C Taieb D Acunzo J Giusiano S Fazli L Gleave M Garrido C Rocchi P Targeting TCTP as a new therapeutic strategy in castration-resistant prostate cancer Mol Ther J American Soc Gene Ther 2012 20 12 2244 2256 10.1038/mt.2012.155
42. Kobayashi D Hirayama M Komohara Y Mizuguchi S Wilson Morifuji M Ihn H Takeya M Kuramochi A Araki N Translationally controlled tumor protein is a novel biological target for neurofibromatosis type 1 (NF1)-associated tumors J Biol Chem 2014 289 38 26314 26326 10.1074/jbc.M114.568253 25092287
43. Bhisutthibhan J Pan XQ Hossler PA Walker DJ Yowell CA Carlton J Dame JB Meshnick SR The Plasmodium falciparum translationally controlled tumor protein homolog and its reaction with the antimalarial drug artemisinin J Biol Chem 1998 273 26 16192 16198 10.1074/jbc.273.26.16192 9632675
44. Efferth T Mechanistic perspectives for 1,2,4-trioxanes in anti-cancer therapy Drug Resist Updat 2005 8 1–2 85 97 10.1016/j.drup.2005.04.003 15878303
45. Fujita T Felix K Pinkaew D Hutadilok-Towatana N Liu Z Fujise K Human fortilin is a molecular target of dihydroartemisinin FEBS Lett 2008 582 7 1055 1060 10.1016/j.febslet.2008.02.055 18325342
47. Seo EJ Efferth T Interaction of antihistaminic drugs with human translationally controlled tumor protein (TCTP) as novel approach for differentiation therapy Oncotarget 2016 7 13 16818 16839 26921194
48. Chung S Kim M Choi W Chung J Lee K Expression of translationally controlled tumor protein mRNA in human colon cancer Cancer Lett 2000 156 2 185 190 10.1016/S0304-3835(00)00460-2 10880768
49. Slaby O Sobkova K Svoboda M Garajova I Fabian P Hrstka R Nenutil R Sachlova M Kocakova I Michalek J Significant overexpression of Hsp110 gene during colorectal cancer progression Oncol Rep 2009 21 5 1235 1241 10.3892/or_00000346 19360299
50. Chu ZH Liu L Zheng CX Lai W Li SF Wu H Zeng YJ Zhao HY Guan YF Proteomic analysis identifies translationally controlled tumor protein as a mediator of phosphatase of regenerating liver-3-promoted proliferation, migration and invasion in human colon cancer cells Chin Med J (Engl) 2011 124 22 3778 3785 22340241
51. Ma Q Geng Y Xu W Wu Y He F Shu W Huang M Du H Li M The role of translationally controlled tumor protein in tumor growth and metastasis of colon adenocarcinoma cells J Proteome Res 2010 9 1 40 49 10.1021/pr9001367 19621893
52. Bommer UA Iadevaia V Chen J Knoch B Engel M Proud CG Growth-factor dependent expression of the translationally controlled tumour protein TCTP is regulated through the PI3-K/Akt/mTORC1 signalling pathway Cell Signal 2015 27 8 1557 1568 10.1016/j.cellsig.2015.04.011 25936523
53. Francipane MG Lagasse E mTOR pathway in colorectal cancer: an update Oncotarget 2014 5 1 49 66 24393708
54. Papadatos-Pastos D Rabbie R Ross P Sarker D The role of the PI3K pathway in colorectal cancer Crit Rev Oncol Hematol 2015 94 1 18 30 10.1016/j.critrevonc.2014.12.006 25591826
55. Wang XW Zhang YJ Targeting mTOR network in colorectal cancer therapy World J Gastroenterol 2014 20 15 4178 4188 10.3748/wjg.v20.i15.4178 24764656
56. Vine KL Locke JM Ranson M Benkendorff K Pyne SG Bremner JB In vitro cytotoxicity evaluation of some substituted isatin derivatives Bioorg Med Chem 2007 15 2 931 938 10.1016/j.bmc.2006.10.035 17088067
57. Roux PP Shahbazian D Vu H Holz MK Cohen MS Taunton J Sonenberg N Blenis J RAS/ERK signaling promotes site-specific ribosomal protein S6 phosphorylation via RSK and stimulates cap-dependent translation J Biol Chem 2007 282 19 14056 14064 10.1074/jbc.M700906200 17360704
58. Friedman DB Hill S Keller JW Merchant NB Levy SE Coffey RJ Caprioli RM Proteome analysis of human colon cancer by two-dimensional difference gel electrophoresis and mass spectrometry Proteomics 2004 4 3 793 811 10.1002/pmic.200300635 14997500
59. Xiao B Chen D Luo S Hao W Jing F Liu T Wang S Geng Y Li L Xu W Extracellular translationally controlled tumor protein promotes colorectal cancer invasion and metastasis through Cdc42/JNK/MMP9 signaling Oncotarget 2016 7 31 50057 50073 27367023
60. Zhang YJ Dai Q Sun DF Xiong H Tian XQ Gao FH Xu MH Chen GQ Han ZG Fang JY mTOR signaling pathway is a target for the treatment of colorectal cancer Ann Surg Oncol 2009 16 9 2617 2628 10.1245/s10434-009-0555-9 19517193
61. Schmidt I Fahling M Nafz B Skalweit A Thiele BJ Induction of translationally controlled tumor protein (TCTP) by transcriptional and post-transcriptional mechanisms FEBS J 2007 274 20 5416 5424 10.1111/j.1742-4658.2007.06069.x 17894822
62. Sturzenbaum SR Kille P Morgan AJ Identification of heavy metal induced changes in the expression patterns of the translationally controlled tumour protein (TCTP) in the earthworm Lumbricus rubellus1 Biochim Biophys Acta 1998 1398 3 294 304 10.1016/S0167-4781(98)00077-3 9655922
63. Yan Y Weaver VM Blair IA Analysis of protein expression during oxidative stress in breast epithelial cells using a stable isotope labeled proteome internal standard J Proteome Res 2005 4 6 2007 2014 10.1021/pr050175d 16335945
64. Yao Y Jia XY Tian HY Jiang YX Xu GJ Qian QJ Zhao FK Comparative proteomic analysis of colon cancer cells in response to oxaliplatin treatment Biochim Biophys Acta 2009 1794 10 1433 1440 10.1016/j.bbapap.2009.06.005 19520192
65. Sinha P Kohl S Fischer J Hutter G Kern M Kottgen E Dietel M Lage H Schnolzer M Schadendorf D Identification of novel proteins associated with the development of chemoresistance in malignant melanoma using two-dimensional electrophoresis Electrophoresis 2000 21 14 3048 3057 10.1002/1522-2683(20000801)21:14 3.0.CO;2-W 11001322
66. De Angelis PM Svendsrud DH Kravik KL Stokke T Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery Mol Cancer 2006 5 20 10.1186/1476-4598-5-20 16709241
67. Silva A Luis D Santos S Silva J Mendo AS Coito L Silva TF da Silva MF Martins LM Pombeiro AJ Biological characterization of the antiproliferative potential of Co(II) and Sn(IV) coordination compounds in human cancer cell lines: a comparative proteomic approach Drug Metabol Drug Interact 2013 28 3 167 176 10.1515/dmdi-2013-0015 23800656
68. Thiele H Berger M Skalweit A Thiele BJ Expression of the gene and processed pseudogenes encoding the human and rabbit translationally controlled tumour protein (TCTP) Eur J Biochem 2000 267 17 5473 5481 10.1046/j.1432-1327.2000.01609.x 10951206
69. Yamashita R Suzuki Y Takeuchi N Wakaguri H Ueda T Sugano S Nakai K Comprehensive detection of human terminal oligo-pyrimidine (TOP) genes and analysis of their characteristics Nucleic Acids Res 2008 36 11 3707 3715 10.1093/nar/gkn248 18480124
70. Meyuhas O Kahan T The race to decipher the top secrets of TOP mRNAs Biochim Biophys Acta 2015 1849 7 801 811 10.1016/j.bbagrm.2014.08.015 25234618
71. Leprivier G Rotblat B Khan D Jan E Sorensen PH Stress-mediated translational control in cancer cells Biochim Biophys Acta 2015 1849 7 845 860 10.1016/j.bbagrm.2014.11.002 25464034
72. Tee AR Proud CG DNA-damaging agents cause inactivation of translational regulators linked to mTOR signalling Oncogene 2000 19 26 3021 3031 10.1038/sj.onc.1203622 10871854
73. Hsu CP Kao TY Chang WL Nieh S Wang HL Chung YC Clinical significance of tumor suppressor PTEN in colorectal carcinoma Eur J Surg Oncol 2011 37 2 140 147 10.1016/j.ejso.2010.12.003 21194879
74. Robert F Pelletier J Translation initiation: a critical signalling node in cancer Expert Opin Ther Targets 2009 13 11 1279 1293 10.1517/14728220903241625 19705976
75. Hsieh AC Costa M Zollo O Davis C Feldman ME Testa JR Meyuhas O Shokat KM Ruggero D Genetic dissection of the oncogenic mTOR pathway reveals druggable addiction to translational control via 4EBP-eIF4E Cancer Cell 2010 17 3 249 261 10.1016/j.ccr.2010.01.021 20227039
76. Mills JR Hippo Y Robert F Chen SM Malina A Lin CJ Trojahn U Wendel HG Charest A Bronson RT mTORC1 promotes survival through translational control of Mcl-1 Proc Natl Acad Sci U S A 2008 105 31 10853 10858 10.1073/pnas.0804821105 18664580
77. Ye Q Cai W Zheng Y Evers BM She QB ERK and AKT signaling cooperate to translationally regulate survivin expression for metastatic progression of colorectal cancer Oncogene 2014 33 14 1828 1839 10.1038/onc.2013.122 23624914
78. Schulze-Bergkamen H Ehrenberg R Hickmann L Vick B Urbanik T Schimanski CC Berger MR Schad A Weber A Heeger S Bcl-x(L) and Myeloid cell leukaemia-1 contribute to apoptosis resistance of colorectal cancer cells World J Gastroenterol 2008 14 24 3829 3840 10.3748/wjg.14.3829 18609706
79. Zou H Lai Y Zhao X Yan G Ma D Cardenes N Shiva S Liu Y Bai X Jiang Y Regulation of mammalian target of rapamycin complex 1 by Bcl-2 and Bcl-XL proteins J Biol Chem 2013 288 40 28824 28830 10.1074/jbc.M113.505370 23960074
80. Hsu Y-C Chern JJ Cai Y Liu M Choi K-W Drosophila TCTP is essential for growth and proliferation through regulation of dRheb GTPase Nature 2007 445 7129 785 788 10.1038/nature05528 17301792
81. Rehmann H Bruning M Berghaus C Schwarten M Kohler K Stocker H Stoll R Zwartkruis FJ Wittinghofer A Biochemical characterisation of TCTP questions its function as a guanine nucleotide exchange factor for Rheb FEBS Lett 2008 582 20 3005 3010 10.1016/j.febslet.2008.07.057 18692051
82. Wang X Fonseca BD Tang H Liu R Elia A Clemens MJ Bommer UA Proud CG Re-evaluating the roles of proposed modulators of mammalian target of rapamycin complex 1 (mTORC1) signaling J Biol Chem 2008 283 45 30482 30492 10.1074/jbc.M803348200 18676370
83. Gil-Ad I Zolokov A Lomnitski L Taler M Bar M Luria D Ram E Weizman A Evaluation of the potential anti-cancer activity of the antidepressant sertraline in human colon cancer cell lines and in colorectal cancer-xenografted mice Int J Oncol 2008 33 2 277 286 18636148
84. Xu W Tamim H Shapiro S Stang MR Collet JP Use of antidepressants and risk of colorectal cancer: a nested case–control study Lancet Oncol 2006 7 4 301 308 10.1016/S1470-2045(06)70622-2 16574545
85. Chubak J Boudreau DM Rulyak SJ Mandelson MT Colorectal cancer risk in relation to antidepressant medication use Int J Cancer 2011 128 1 227 232 10.1002/ijc.25322 20232382
86. Lin CJ Robert F Sukarieh R Michnick S Pelletier J The antidepressant sertraline inhibits translation initiation by curtailing mammalian target of rapamycin signaling Cancer Res 2010 70 8 3199 3208 10.1158/0008-5472.CAN-09-4072 20354178
87. Bommer UA Lazaris-Karatzas A De Benedetti A Nurnberg P Benndorf R Bielka H Sonenberg N Translational regulation of the mammalian growth-related protein P23: involvement of eIF-4E Cell Mol Biol Res 1994 40 7–8 633 641 7787881
88. Bommer UA Borovjagin AV Greagg MA Jeffrey IW Russell P Laing KG Lee M Clemens MJ The mRNA of the translationally controlled tumor protein P23/TCTP is a highly structured RNA, which activates the dsRNA-dependent protein kinase PKR RNA 2002 8 4 478 496 10.1017/S1355838202022586 11991642
89. Li F Zhang D Fujise K Characterization of fortilin, a novel antiapoptotic protein J Biol Chem 2001 276 50 47542 47549 10.1074/jbc.M108954200 11598139
90. Graidist P Phongdara A Fujise K Antiapoptotic protein partners fortilin and MCL1 independently protect cells from 5-fluorouracil-induced cytotoxicity J Biol Chem 2004 279 39 40868 40875 10.1074/jbc.M401454200 15262975
91. He S Huang Y Wang Y Tang J Song Y Yu X Ma J Wang S Yin H Li Q Histamine-releasing factor/translationally controlled tumor protein plays a role in induced cell adhesion, apoptosis resistance and chemoresistance in non-Hodgkin lymphomas Leuk Lymphoma 2015 56 7 2153 2161 10.3109/10428194.2014.981173 25363345
92. Zheng Y Zhou J Tong Y Gene signatures of drug resistance predict patient survival in colorectal cancer Pharmacogenomics J 2015 15 2 135 143 10.1038/tpj.2014.45 25179828
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.